Sandoz Vietnam doubles down to combat AMR in second year of campaign
Xem Tiếng Việt 
- Sandoz Vietnam partners with Vietnam Medical Association for the second year of their nationwide campaign to raise awareness of antimicrobial resistance (AMR)
- The collaboration supports Vietnam’s AMR National Strategy (2023–2030) and promotes responsible antibiotic use
- Nationwide rollout in 2025 combines medical expertise and community engagement to protect antibiotic effectiveness
Sandoz, the global leader in affordable medicines, today signed a Collaboration Agreement with the Vietnam Medical Association (VMA) to launch a nationwide Antimicrobial Resistance (AMR) Awareness Campaign, reinforcing its commitment to responsible antibiotic use and sustainable healthcare in Vietnam.
The collaboration underscores the importance of collective responsibility in combating AMR – from policymakers and medical professionals to everyday citizens. By promoting awareness and behavioral change, the campaign seeks to safeguard the effectiveness of antibiotics and contribute to a healthier, more resilient Vietnam.
The signing ceremony was attended by representatives from the World Health Organization (WHO) and the Embassy of Switzerland, alongside medical experts, healthcare professionals, and the media.
“Today’s signing is another important step in our shared mission to combat antimicrobial resistance – a silent but growing threat to public health in Vietnam and around the world,” said Charaf Eddine Kadri, General Director of Sandoz Vietnam. “Through this collaboration with the VMA, we aim to empower patients, families and healthcare professionals to take collective action in preserving the effectiveness of antibiotics for future generations.”
This collaboration marks another milestone in Sandoz Vietnam’s ongoing support for the National Strategy on the Prevention of AMR (2023–2030), which emphasizes the “One Health” approach1 and cross-sector coordination to reduce antibiotic misuse, raise awareness and protect public health. According to the World Health Organization (WHO), nearly 300,000 deaths in Vietnam between 2020 and 2023 were linked to antibiotic resistance,2 underscoring the urgency of national and community-level action.
Last year, Sandoz Vietnam launched its inaugural community program on AMR under the theme “Antibiotics: Invisible Threat, Visible Love.” The five-year campaign (2024–2028) was the first of its kind by a pharmaceutical company in Vietnam, implemented in collaboration with a professional medical society. It has reached millions nationwide through a mix of billboards, hospital activation booths and digital outreach, engaging both healthcare professionals and the public on responsible antibiotic use.
This year’s campaign, launched under the new Collaboration Agreement with VMA, will scale up those efforts with expanded educational activities, public events and stronger community engagement. The initiative aims to make antibiotic awareness more accessible, relatable and actionable for Vietnamese families.
“AMR is a security threat, an economic threat and a development threat,” said Thomas Gass, Ambassador, Embassy of Switzerland in Vietnam. “Switzerland is committed to playing a direct and long-standing role in the global fight against AMR, through the Global Antibiotic Research & Development Partnership (GARDP), the Global AMR R&D Hub, the Quadripartite Joint Secretariat on AMR (WHO, FAO, WOAH, UNEP), and the AMR Multi-Partner Trust Fund. Switzerland also contributes through its private sector — including companies like Sandoz, which plays a globally substantial and measurable role.”
“One of the key priorities for future action is to strengthen the ‘multisectoral’ approach to AMR — because AMR is an issue which no one organization, and no single sector, can solve alone. But multisectoral-ism is easy to say, harder to do — which is why I am genuinely delighted to be here for the formalizing of this partnership between Sandoz and the Viet Nam Medical Association. From WHO’s perspective – and I believe strongly – the pharmaceutical industry has a crucially important role to play in tackling AMR,” said Dr Angela Pratt – WHO Representative in Viet Nam. “We need the whole industry to continue to
support responsible manufacturing, stronger antimicrobial stewardship, data sharing, and collaborative efforts to continue to ensure quality of and access to a reliable supply of essential medicines.”
Under the Collaboration Agreement, Sandoz Vietnam will fund and help organize the program in compliance with all legal and regulatory requirements, leading its implementation and using both internal and external channels to amplify its message. This covers all campaign activities – from logistics and communications to public engagement – reflecting the company’s long-term commitment to advancing Vietnam’s healthcare priorities through education and awareness.
The Vietnam Medical Association will provide professional consultation, content evaluation and endorsement of all educational materials. The Association will also coordinate implementation at healthcare facilities and public locations, and promote the campaign via its official communication platforms.
“The issue of antimicrobial resistance requires collective action,” said Assoc. Prof. Dr. Nguyen Thi Xuyen, President of the Vietnam Medical Association. “As medical professionals, we have a responsibility to guide both our colleagues and the public toward more responsible antibiotic use. We value this partnership with Sandoz Vietnam, which combines our medical expertise with their strong community engagement, helping translate scientific knowledge into real-world behavioral change.”
“At Sandoz, our advocacy for responsible antibiotic use is embedded in our DNA,” Mr. Kadri concluded. “Together with VMA and our public health partners, we can make a lasting impact – not just for today, but for the future of Vietnam’s health.”
REFERENCES
1 https://onehealth.org.vn/overview.news
2 https://en.baochinhphu.vn/strategy-on-antimicrobial-resistance-released-111230927113608601.htm
